Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Teva
QuintilesIMS
Federal Trade Commission
Merck
Citi
Express Scripts
Fuji
Johnson and Johnson
Deloitte

Generated: February 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,583,131

« Back to Dashboard

Summary for Patent: 5,583,131
Title: Aromatic-linked polyamine macrocyclic compounds with anti-HIV activity
Abstract:Polyamine macrocyclic compounds, e.g. of 10 to 15 ring members and 3 to 6 ring amine nitrogens, linked through methylene groups to an aromatic moiety, show high selective activity against HIV.
Inventor(s): Bridger; Gary J. (West Chester, PA), Padmanbhan; Sreenivasan (Exton, PA), Skerlj; Renato T. (West Chester, PA), Thornton; David M. (Reading, PA)
Assignee: Johnson Matthey Public Limited Company (London, GB)
Application Number:08/244,863
Patent Claim Types:
see list of patent claims
Composition; Compound;

Drugs Protected by US Patent 5,583,131

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,583,131

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom91/26677Dec 16, 1991
PCT Information
PCT FiledDecember 16, 1992PCT Application Number:PCT/GB92/02334
PCT Publication Date:June 24, 1993PCT Publication Number: WO93/12096

International Patents Family Members for US Patent 5,583,131

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Colorcon
Daiichi Sankyo
Deloitte
Cerilliant
Harvard Business School
Baxter
Accenture
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot